(Q41023181)

25 September 2017

1 reference

title

Targeted drug delivery for boron neutron capture therapy (English)

1 reference

25 September 2017

1 reference

S C Mehta

1

1 reference

25 September 2017

D R Lu

series ordinal

2

1 reference

25 September 2017

publication date

1 March 1996

1 reference

25 September 2017

published in

Pharmaceutical Research

1 reference

25 September 2017

volume

13

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

344-351

1 reference

Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats

25 September 2017

cites work

1 reference

12 December 2020

Preparation of sulfhydrylborane-dextran conjugates for boron neutron capture therapy

1 reference

12 December 2020

Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules

1 reference

12 December 2020

Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model

1 reference

12 December 2020

Model studies directed toward the boron neutron-capture therapy of cancer: boron delivery to murine tumors with liposomes.

1 reference

12 December 2020

Boron neutron capture therapy for cancer. Realities and prospects.

1 reference

12 December 2020

Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound

1 reference

12 December 2020

Present Status of Boron Neutron Capture Therapy

1 reference

12 December 2020

Boron therapy gets early test.

1 reference

12 December 2020

Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma

1 reference

12 December 2020

Boronated metalloporphyrins: a novel approach to the diagnosis and treatment of cancer using contrast-enhanced MR imaging and neutron capture therapy.

1 reference

12 December 2020

Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors

1 reference

12 December 2020

Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors

1 reference

12 December 2020

Boron uptake in melanoma, cerebrum and blood from Na2B12H11SH and Na4B24H22S2 administered to mice.

1 reference

12 December 2020

Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation.

1 reference

12 December 2020

Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy

1 reference

12 December 2020

Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential

1 reference

12 December 2020

Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma

1 reference

12 December 2020

Boron neutron capture therapy of cancer.

1 reference

12 December 2020

Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine

1 reference

12 December 2020

The pharmacokinetics of p-Boronophenylalanine.fructose in human patients with glioma and metastatic melanoma

1 reference

12 December 2020

Present status and perspectives of boron neutron capture therapy.

1 reference

12 December 2020

Boron neutron capture therapy of a murine melanoma

1 reference

12 December 2020

Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy

1 reference

12 December 2020

Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture.

1 reference

12 December 2020

New developments in neutron capture therapy.

1 reference

12 December 2020

Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron Compounds

1 reference

12 December 2020

Interspecies pharmacokinetic scaling of BSH in mice, rats, rabbits, and humans.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016076022267

1 reference

25 September 2017

1 reference